Fort Dodge Animal Health is an American pharmaceutical manufacturing company based in Overland Park, Kansas.
History
Scientists at Fort Dodge Laboratories and the Centers for Disease Control and Prevention developed a DNA vaccine against West Nile virus (WNV).[1]
It was licensed by the United States Department of Agriculture (USDA) on July 18, 2005, becoming the first DNA vaccine approved by a regulatory agency for either veterinary or human use.[2][3]
External links
Davis, B. S., Chang, G.-J. J., Cropp, B., Roehrig, J. T., Martin, D. A., Mitchell, C. J., Bowen, R., & Bunning, M. L. (2001). West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays.Journal of Virology, 75(9), 4040–4047. https://doi.org/10.1128/jvi.75.9.4040-4047.2001 ↩︎
Lu, S., Grimes-Serrano, J. M., & Wang, S. (2009). DNA Vaccines for Biodefense and Emerging and Neglected Infectious Diseases. Elsevier EBooks, 93–114. https://doi.org/10.1016/b978-0-12-369408-9.00008-1 ↩︎
Barakat, C. (2020, December 15). The equine contribution to the new CoVID-19 vaccine. Equus Magazine. http://archive.today/2022.08.30-160826/https://equusmagazine.com/news/horses-contribute-covid-vaccine/ ↩︎
